Brand profile · Biotechnology Research

Starpharma

Starpharma is a Biotechnology Research brand in Abbotsford, Victoria. Ownership is publicly held; it publishes at starpharma.com. It holds one address on record, all in Australia. The record counts 80 people. Tagged pharmaceuticals and medical devices. Two Australian registrations (ABN) are candidate matches. Its latest round on record is Post IPO equity, US$32.2M. It is listed alongside nine similar brands, mostly in Biotechnology Research.

Profile live Public Company Founded 1996 2 registry matches ABN 1 office country US$ 32.2M Post IPO equity
Registry match · ABR

Key facts

Counted staff
80
self-reported 11–50 band
Founded
1996
30 years
Registry matches
2
ABR
Office countries
1
1 address
Funding rounds
1
Post IPO equity · Oct 2020 · US$ 32.2M
Company type
Public Company
self-reported
Use this profile Compare Your shortlist

Legal entities

1 brand → 2 possible registrationsThese are name matches on ABR. 2 registrations share this brand's name; which one you contract with is a question for the register.
  • STARPHARMA PTY LTD

    ABN86075081908

    VICMedium confidenceMatched on exact nameABR

  • STARPHARMA HOLDINGS LIMITED

    ABN20078532180

    VICMedium confidenceMatched on exact nameABR

Legal entities

Starpharma: 2 registry entitiesStarpharma is linked to 2 registry entities: STARPHARMA PTY LTD (ABN 86075081908, candidate); STARPHARMA HOLDINGS LIMITED (ABN 20078532180, candidate).StarpharmaSTARPHARMA PTY LTDABN 86075081908Candidate · Medium confidenceSTARPHARMA HOLDINGSLIMITEDABN 20078532180Candidate · Medium confidence
Show as table · Starpharma: 2 registry entities
Starpharma: 2 registry entities
STARPHARMA PTY LTDABN 86075081908
STARPHARMA HOLDINGS LIMITEDABN 20078532180
Confirmed matches0 of 2

A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.

Description

Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) is a global biopharmaceutical company and a world leader in the development of new pharmaceutical and medical products based on proprietary polymers called dendrimers, with programs for respiratory viruses, DEP® drug delivery and VivaGel®.

Specialties

All 3 specialties
  • Medical Devices
  • Pharmaceuticals
  • Dendrimer Drug Delivery

Locations

Country footprint

Offices in 1 countryCountry footprint: 1 country, primary AU. Codes: AU.1 countryprimary AUAU
Show as table · Offices in 1 country
Offices in 1 country
Countries1
Primary countryAU

All codes: AU

Addresses

  • AU4-6 Southampton Crescent; ABBOTSFORD, Victoria 3067Primary

Grid intelligence Members

Funding

Last round · 30 October 2020US$ 32.2MPost IPO equity
Rounds1
Round typePost IPO equity · secondary transaction
Amount (USD)32,200,000
Stage rank6
Investors named0
Since last round5 yr 2 mo

Funding

1 funding roundFunding timeline. Latest round 30 Oct 2020: Post IPO equity, US$ 32.2M.19962026Post IPO equityUS$ 32.2M1 round
Show as table · 1 funding round
1 funding round
Rounds1
Axis1996 to 2026
Post IPO equity · 30 Oct 2020US$ 32.2M

Dated rounds only. The axis ends at the date this profile was last observed, not at today.

Spending power

TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.

Spending power

Signals & hiring

Hiring, headcount and registry-change signals, streamed to members.

Latest signal
Hiring activity
Headcount trend

Financials

Registry-filed capital and financial indicators, standardised by TheGrid.

Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss

People & contacts

4 employee profiles on record · names withheld.

Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.

Counts only. No names are stored here, and none are served.

Notify me about contacts Tell us who you need to reach and we will tell you when a consented source is live.

FAQ

Which legal entities operate under Starpharma?

Two Victoria entities on the ABR. STARPHARMA PTY LTD (ABN 86 075 081 908) and STARPHARMA HOLDINGS LIMITED (ABN 20 078 532 180). Both medium confidence.

How many people work at Starpharma?

The record holds 80 counted staff profiles at January 2026, above the self-reported 11–50 band.

Where does Starpharma have offices?

One address on record, Australia only. Primary: 4-6 Southampton Crescent, ABBOTSFORD, Victoria 3067.

Has Starpharma raised funding?

One round. Latest 30 October 2020: post IPO equity, US$32,200,000.

What does Starpharma list as its specialties?

Three tags on the brand's own list, among them pharmaceuticals and medical devices.

Which companies are listed alongside Starpharma?

27 profiles list Starpharma as a peer — 96th percentile in Biotechnology Research. It lists ten peers of its own. Biocelect Pty Ltd and Mesoblast Limited list it back.

What is Starpharma's website?